Healthcare IPO filings last week

 

Filings During the Week of January 18th, 2021
Issuer Business	Deal Size	Sector	Lead Underwriter
Decibel Therapeutics (DBTX)	$75M	Health Care	Citi
Phase 1 biotech developing treatments for hearing and balance disorders.
Talis Biomedical (TLIS)	$150M	Health Care	JP Morgan
Developing diagnostic tests for COVID-19 and other infectious diseases.
Isleworth Healthcare Acq. (IHAU.RC)	$150M	SPAC	I-Bankers
Blank check company targeting healthcare innovation.
Priveterra Acquisition (PMGMU)	$200M	SPAC	Wells Fargo
Blank check company targeting the medical technology sector.
Bioventus (BVS)	$100M	Health Care	Morgan Stanley
Offers orthobiologics products for musculoskeletal conditions.
Compute Health Acq. (CPUH.U)	$750M	SPAC	Goldman
Blank check company targeting the intersection of computation and healthcare.
HH&L Acquisition (HHLA.U)	$300M	SPAC	Goldman (Asia)
Blank check company targeting the healthcare sector in Asia.
Adagene (ADAG)	$125M	Health Care	Goldman (Asia)
Phase 1 biotech developing antibody cancer immunotherapies in China.
Biophytis (BPTS)	$15M	Health Care	HC Wainwright
French Phase 2 biotech developing therapies for COVID-related complications and age-related diseases.
Decipher Biosciences (DECI)	$100M	Health Care	Evercore ISI
Provides genomic testing products for urologic oncology.
Longeveron (LGVN)	$30M	Health Care	Kingswood Cap. Mkts.
Phase 2 biotech developing cellular therapies for aging-related conditions.
NexImmune (NEXI)	$86M	Health Care	Barclays
Phase 1/2 biotech developing T cell immunotherapies for cancer.
Signify Health (SGFY)	$500M	Health Care	Goldman
Provides a value-based billing platform for in-home and bundled health services. https://www.renaissancecapital.com/IPO-Center/News/75527/US-IPO-Weekly-Recap-The-IPO-market-has-no-time-to-RLX-in-a-6-IPO-week